SCHEMBL18907332

SCHEMBL18907332

c1ccc2c(c1)ccc1c2c(-c2c3ccccc3c(-c3ccncc3)c3ccccc23)nc2ccc3ccccc3c21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
KDM4E B2RXH2 6/20 0.49
HPGD P15428 5/20 0.49
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.42
CYP1A2 P05177 2/20 0.37
POLB P06746 2/20 0.37
CYP1A1 P04798 1/20 0.37
CFTR P13569 1/20 0.37
CYP1B1 Q16678 1/20 0.37
RAB9A P51151 4/20 0.37
CYP3A4 P08684 3/20 0.37
NPC1 O15118 3/20 0.37
AR P10275 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 5/20 0.36
HTT P42858 2/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907414 0.86 MAPT (0.50) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL18907421 0.85 ESR1 (0.46) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL18907412 0.83 MAPT (0.40) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL18907289 0.77 MAPT (0.40) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL17034919 0.74 KDM4E (0.46) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL29538964 0.72 NOTUM (0.57) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL11910167 0.72 NOTUM (0.57) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL15004434 0.72 CYP1A2 (0.44) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL17034920 0.71 KDM4E (0.46) MAPTKDM4EHPGDALDH1A1SMN1; SMN2
SCHEMBL18907348 0.70 MAPK10 (0.41) MAPTKDM4EHPGDALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 MAPT 2043/4885KDM4E 2914/4885HPGD 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.